Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells

Li Wang1, Robert C MacDonald

  • 1Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208, USA.

Insights

Encapsulating 8-substituted adenosine triphosphate (ATP) analogs into cationic liposomes enhances their delivery and efficacy against multiple myeloma. This novel approach overcomes drug limitations, improving cancer treatment potential.

Area of Science:

  • Biochemistry and Molecular Biology
  • Nanotechnology in Medicine
  • Cancer Therapeutics

Background:

  • Adenosine triphosphate (ATP) analogs with 8-position substitutions show promise as cytotoxic agents against multiple myeloma.
  • Limitations include poor biological membrane permeability and sensitivity to phosphatases in bodily fluids.
  • Cationic phospholiposomes offer a potential delivery vehicle to overcome these challenges.

Purpose of the Study:

  • To develop and evaluate cationic liposomes for encapsulating 8-substituted ATP analogs.
  • To assess the efficacy and cellular uptake of encapsulated drugs compared to free drugs.
  • To investigate the role of liposome composition and preparation methods on encapsulation and drug release.

Main Methods:

  • Encapsulation of 8-Br-ATP and 8-NH₂-ATP into cationic liposomes (EDOPC and EDPPC) using vortexing.
  • Inclusion of cholesterol to improve encapsulation efficiency for specific analogs.
  • Cytotoxicity assays on multiple myeloma cells and intracellular distribution studies using fluorescent markers.

Main Results:

  • Vortexing proved more efficient than freeze-thawing for liposome encapsulation.
  • EDOPC:cholesterol liposomes (55:45 mole/mole) achieved ~40% encapsulation of 8-NH₂-ATP.
  • Encapsulated drug demonstrated up to 10-fold greater efficacy in multiple myeloma cell cultures.
  • Liposomal encapsulation significantly increased cellular uptake of ATP analogs.

Conclusions:

  • Cationic phospholiposomes effectively encapsulate 8-substituted ATP analogs, enhancing their anti-myeloma activity.
  • Liposome composition, particularly cholesterol inclusion, influences encapsulation and drug retention.
  • This liposomal drug delivery system presents a promising strategy for improving multiple myeloma treatment.